Immunogenicity, Efficacy, and Effectiveness of Two-Dose and Shorter Schedules of Hepatitis E Vaccine: A Systematic Review

Immunogenicity, Efficacy, and Effectiveness of Two-Dose and Shorter Schedules of Hepatitis E Vaccine: A Systematic Review

<b>Background</b>: Hepatitis E virus (HEV) is a leading cause of acute viral hepatitis in adults. The schedule for HEV 239, the only approved anti-HEV vaccine, consists of three doses at 0, 1, and 6 months, which is unsuitable for use in emergency and outbreak situations where quick prot...

Full description

Saved in:
Bibliographic Details
Main Authors: Bilal Azam, Melanie Marti, Amit Goel, Rakesh Aggarwal
Format: Article
Language:English
Published: MDPI AG 2024-12-01
Series:Vaccines
Subjects:
hepatitis E
HEV 239
shorter schedule
immunogenicity
efficacy
Online Access:https://www.mdpi.com/2076-393X/13/1/28
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items